We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Aron Gyorgypal, PhD

Aron Gyorgypal, PhD

Dr. Aron Gyorgypal is a postdoctoral research fellow at Harvard Medical School and Massachusetts General Hospital in Boston, Massachusetts. Traditionally trained as an engineer, Aron received his PhD in chemical and biochemical engineering from Rutgers University in New Jersey, where he studied antibody glycosylation in the context of bioprocessing to produce more homogeneous biologics. He utilizes his expertise as a consultant for biopharmaceutical companies to help better develop biosimilars. Following the completion of his PhD, he joined the Anthony Lab at Harvard Medical School and Massachusetts General Hospital in the immunology department, where he leverages his engineering skillset to deepen the understanding of immunological disorders and develop therapeutic solutions against such conditions. Some key topics Aron is interested in are oncology, immunology, neurobiology and glycobiology.


Got a question for Aron Gyorgypal, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 6
A diagram showing the steps of CAR T-cell therapy
Article

The Applications of Cell Therapy

Cell therapy refers to the transplantation of human cells to either replace or repair damaged tissues and/or cells. In this article, we expand upon the applications of cell therapy, including its utility in cancer, regenerative medicine and autoimmunity.
Stem cells
Article

An Introduction to Cell Therapy

The term cell therapy refers to the transfer of cellular materials into a patient for therapeutic purposes. Here, we look to introduce the different types of cell therapies, including stem-cell and non-stem cell-based unicellular therapies as well as multicellular therapies.
Antibodies
Article

Biologic Production and Host Cell Proteins

Host cell proteins can prove problematic for the development of novel biopharmaceuticals. This article will highlight some of the latest advances in host cell analysis strategies and how they are being implemented.
New Advances in the Bioprocess Pipeline
Listicle

New Advances in the Bioprocess Pipeline

The ever-advancing bioprocess pipeline aims to optimize the manufacturing of biologics, using living organisms or their components. Addressing challenges of high costs, time-consuming assays and processing complexities is a key part of this process.
A scientist uses a pipette while wearing blue gloves. The image is overlaid with white dots and lines to represent a network.
Article

Embracing Data-Driven Modeling Approaches Into Biopharmaceutical Processing

This article explores new workflows using data-driven modeling to improve culture medium and new control algorithms allowing for better modulation within the bioprocess design space.
Emerging Technological Landscapes in Biomanufacturing and Monoclonal Antibody Screening content piece image
Article

Emerging Technological Landscapes in Biomanufacturing and Monoclonal Antibody Screening

This article aims to understand the current challenges in biomanufacturing and screening mAb profiles, and how innovative tools allow for greater insight when monitoring the critical attributes of mAbs.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter